Drug intelligence / Profile preview

decursin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

Decursin is a **pyranocoumarin compound** (C19H20O5) isolated mainly from the roots of *Angelica gigas*, a medicinal plant in the Umbelliferae family[1][2][4][5][7]. It is a rare secondary metabolite and has been used in traditional folk medicine. Mechanistically, decursin exhibits pleiotropic bioactivities, including **anticancer**, **anti-inflammatory**, **anti-angiogenic**, **anti-obesity**, **antibacterial**, and **neuroprotective effects**. In cancer, it inhibits cell proliferation, angiogenesis, metastasis, and invasion, induces cell cycle arrest and apoptosis, and modulates pathways such as the MAPK/ERK1/2, PI3K/AKT, Pin1/p53, and Bcl-2/Bax[1]. It also affects VEGF-induced angiogenesis by blocking VEGFR-2 activation and can suppress JAK2/STAT3 signaling[1]. Neuroprotective mechanisms include inhibition of Acetylcholine esterase, reduction of glutamate-induced calcium influx, activation of antioxidative defense (Nrf2/HO-1 path), and inhibition of Aβ aggregation[4].

Other names
Decursinol angelateDecurson(S)-(+)-decursinDECURSIN USP/EP/BPDecursin - Bio-XDecursinDecursin, 98%, from Angelica decursiva
02

Targets

HIF1A (Hypoxia-inducible factor 1-alpha)STAT3 (Signal Transducer and Activator of Transcription 3)MAOA (Monoamine oxidase A)CXCR7 (CXC chemokine receptor 7)Cyclin D1-Cyclin-dependent kinase 4/6 complexAR (Adrenergic receptors)

Beyond the preview

Go deeper on decursin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on decursin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call